ACIP drops recommendation of LAIV/nasal spray for 2016-2017 flu season

 

As many of you already know, ACIP voted to remove Flumist® from the list of recommended flu presentations for the 2016-2017 season. More specifically:

“CDC’s Advisory Committee on Immunization Practices (ACIP) today voted that live attenuated influenza vaccine (LAIV), also known as the “nasal spray” flu vaccine, should not be used during the 2016-2017 flu season. ACIP continues to recommend annual flu vaccination, with either the inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV), for everyone 6 months and older. ACIP is a panel of immunization experts that advises the Centers for Disease Control and Prevention (CDC). This ACIP vote is based on data showing poor or relatively lower effectiveness of LAIV from 2013 through 2016.”

-www.cdc.gov/media/releases/2016/s0622-laiv-flu.html

 

To help you better communicate this message to your patients and staff, here are two excellent primer articles:

1. “No Flu Nasal Spray Next Season: Why Is This Vaccine Not Working?” Livescience.com, June 23, 2016, www.livescience.com/55176-flu-nasal-spray-not-working.html

2. “Intranasal FluMISSED its target.” aappublications.org, July 12, 2016, www.aappublications.org/news/2016/07/12/LAIV071216

If you have further questions about how this will affect your clinic’s state-supplied flu order, please call Jennifer Steinbock at 971-673-0309.

 

 

Comments Off on ACIP drops recommendation of LAIV/nasal spray for 2016-2017 flu season

Filed under ACIP, All Posts, Flu, Oregon Immunization

Comments are closed.